Edit |   |
---|---|
Antigenic Specificity | CD279, Human (Pembrolizumab biosimilar) |
Clone | Pembrolizumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG4 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD279 Recombinant Antibody (Pembrolizumab). Pembrolizumab, sold under the brand name Keytruda, is a humanized antibody used in cancer immunotherapy that treats melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, and stomach cancer. It is given by slow injection into a vein. |
Immunogen | n/a |
Other Names | Anti-CD279 Recombinant Antibody, Research Grade Pembrolizumab, Anti-Human CD279 Recombinant Antibody(Pembrolizumab), MK-3475, Antibody Drug Analogues, Monoclonal Antibody, YR1012, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1374853-91-4 |
Catalog # | YR1012 |
Price | please inquire |
Order / More Info | CD279, Human (Pembrolizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |